A Phase II Trial of Prolonged Oral Etoposide (VP-16) as Second-Line Therapy for Advanced and Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G.   Blessing J.A.   Lewandowski G.S.   Creasman W.T.   Webster K.D.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 101-104

Academic Press

Access to resources Recommend Favorite

Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group

By van Wijk F.H.   Lhomme C.   Bolis G.   Scotto di Palumbo V.   Tumolo S.   Nooij M.   de Oliveira C.F.   Vermorken J.B.  

European Journal of Cancer, Vol. 39, Iss. 1, 2003-01 ,pp. : 78-85

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G.   Brunetto V.L.   VanLe L.   Bell J.   Walker J.L.   Lee R.B.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 212-216

Elsevier

Access to resources Recommend Favorite

Treatment of Advanced or Recurrent Endometrial Carcinoma with Combination of Etoposide, Cisplatin, and 5-Fluorouracil: A Phase II Study

By Pierga J.Y.   Dieras V.   Paraiso D.   Dorval T.   Palangie T.   Beuzeboc P.   Jouve M.   Scholl S.M.   Garcia-Giralt E.   Pouillart P.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 59-63

Academic Press

Access to resources Recommend Favorite

A Phase II Trial of Topotecan in Patients with Advanced, Persistent, or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Miller D.S.   Blessing J.A.   Lentz S.S.   Waggoner S.E.  

Gynecologic Oncology, Vol. 87, Iss. 3, 2002-12 ,pp. : 247-251

Academic Press

Access to resources Recommend Favorite